PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34552882-0	2021	Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway.	Erlotinib Hydrochloride	53-62	microRNA 1227	Homo sapiens	124-132	
34552882-12	2021	Rescue assays highlighted that circ_0013587 reversed erlotinib resistance in pancreatic cancer cells by increasing E-cadherin levels through reducing the expression of miR-1227.	Erlotinib Hydrochloride	53-62	microRNA 1227	Homo sapiens	168-176	
34552882-14	2021	Conclusions: Our results demonstrated that down-regulation of circ_0013587 contributes to acquired resistance to erlotinib in pancreatic cancer cells through mediating the miR-1227/E-cadherin pathway and that circ_0013587 is a potential target molecular to overcome erlotinib resistance.	Erlotinib Hydrochloride	113-122	microRNA 1227	Homo sapiens	172-180